Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06884059 · ClinicalTrials.gov registry record · Phase 1
Time Restricted Eating in Patients With Microalbuminuria
A Phase 1 study, sponsored by University of California, San Diego.
- Not yet
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT06884059: Clinical Trial Phase 1 study, sponsored by University of California, San Diego.
NCT06884059 is a Phase 1 study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 25 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06884059, a Phase 1 study, has not yet begun recruiting, sponsored by University of California, San Diego.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
Primary Outcome
Change in uACR (mg/g) assessed via urine sample
Interventions
- BEHAVIORAL Time Restricted Eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-03 |
| Est. Completion | 2028-02 |
| Phase | Phase 1 |
What is known before NCT06884059 opens enrollment
NCT06884059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which Time Restricted Eating is the first listed.
NCT06884059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06884059 about?
NCT06884059 is a clinical study titled "Time Restricted Eating in Patients With Microalbuminuria". This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
What is the current status of trial NCT06884059?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2025-03. Estimated completion is 2028-02.
What interventions are being tested in trial NCT06884059?
The interventions under investigation include: Time Restricted Eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT06884059?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06884059's enrollment target sits among peer trials
25 1495th of 2000 higher than 481 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia